ABBV News and Press, AbbVie Inc.

2026-07-12 09:05:05 ET More on State Street Health Care Select Sector SPDR ETF Soft Landing Myth: How This Week's Data Exposed The Hidden Recession Big Pharma's Looming Patent Cliff Period And How It Is Trying To Address It AI Revolutionizing Biopharma: Faster, Bette...

2026-07-11 20:35:00 ET AbbVie (NYSE: ABBV) is listed as a Dividend King, but in fairness, it has only been a stand-alone company since it was spun off from Abbott (NYSE: ABT) at the start of 2013. AbbVie hasn't been around for the 50 years required to qualify as a Dividend K...

2026-07-11 11:00:00 ET Get ahead of the market by subscribing to Seeking Alpha's Wall Street Week Ahead, a preview of key events scheduled for the coming week. The newsletter keeps you informed of the biggest stories set to make headlines, including upcoming IPOs, investor days, earnings re...

2026-07-10 17:55:32 ET Introduction The Dividend Champions list is a monthly compilation of companies that have consistently increased their annual dividend payouts. However, since this list is only produced once per month, the data in it can quickly get out of date. Furthermore, wi...

2026-07-10 15:00:57 ET More on JPMorgan Chase, United Airlines, etc. JPMorgan Chase: Buy Ahead Of Q2 Report On Credit Market And Profits Netflix: A Knife Actually Worth Catching Netflix Q2 Preview: Live Programming Presents Opportunity, Shares A Hold Netflix ...

2026-07-10 12:26:38 ET More on ClearBridge International Growth Fund; FI, AbbVie, etc. SAP's Transformation Is Game-Changing AbbVie: Apogee Deal Just Widened An Already Dominant Moat AbbVie Inc. (ABBV) Apogee Therapeutics, Inc. - M&A Call - Slideshow ...

2026-07-10 09:18:32 ET More on the Markets It's Time To Buy Gold And Silver Start Investing At 60 And Retire On Dividends Forever Labor Market Frozen, Fed PUT On Ice Diversification wins: 25/25/25/25 portfolio posts best year since 2021 Spike in optio...

2026-07-10 08:25:56 ET More on markets 25 stocks up over 25% in 2026 that all analysts agree are Buys Slower AI payoff poses broad risks for markets and the economy, Apollo warns Citi sees the next Fed move as a hike and not a cut, amid reduced guidance US3...

One Formula, One Platform: Inside the Preclinical Milestone Behind Conexeu's Move Into Medical Aesthetics PR Newswire Issued on behalf of Conexeu Sciences Inc. Conexeu Sciences Inc. (NASDAQ: CNXU) completed the 12-month P.R.O.O.F phase of its CXU preclinical program, which met i...

2026-07-08 17:12:48 ET More on Big Pharma Johnson & Johnson: Stronger Fundamentals, But Too Much Optimism Novo Nordisk Loses Its Edge, And I'm Downgrading Novartis' Pipeline Building Continues, Pelacarsen Readout Coming Soon Moderna appoints Michael McDon...